MED vs HRB
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 24, 2026
MED
HRB
Investment Advisor Scores
HRB
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MED | HRB | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.4844 | 8.285 | HRB |
| PEG Ratio | 0.972 | 0.663 | HRB |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -27.6% | 3.0% | HRB |
| Earnings Growth | -87.2% | 4.5% | HRB |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.7/100 | 24.9/100 | MED |
| Profit Margin | -8.1% | 18.6% | HRB |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MED
NeutralMixed signals - no dominant trend phase, RSI 58
HRB
MarkupPrice above SMA50, rising 50-day trend (10.6% over 20 days), RSI 69
Fundamentals Snapshot
| Metric | MED | HRB |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -42.7 | 8.1 |
| Trailing P/E | — | 9.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | 0.0% |
| Gross Margin | 0.7% | 0.4% |
| Operating Margin | -0.1% | 0.3% |
| EPS | -2.34 | 5.69 |
| Dividend Yield | — | 0.03% |